NDC 51662-1238
Naloxone Hydrochloride 0.4 mg per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hospira, Inc.'s NDC 0409-1782.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | McPherson, KS, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyJan 17, 2025 · 16 inspections, 2 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Jun 4, 2018 · Class I · Hospira Inc, Lake Forest
Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
Lots: 72680LL, Exp. 1DEC2018 (NDC 0409-1782-03); 76510LL, Exp. 1APR2019 (NDC 0409-1782-69)
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Naloxone: every company that makes it
- Form
- injection, solution, intramuscular; intravenous; subcutaneous
- Strength
- 0.4 mg per 1 mL
- Approval
- ANDA ANDA070172
- On the market since
- Sep 3, 2018
- Package NDCs
51662-1238-1- Official label
- DailyMed (National Library of Medicine), updated Dec 9, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?